6 studies found for:    9819446 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients
Condition: Hepatitis C, Chronic
Intervention: Drug: Pegylated interferon alfa-2a plus ribavirin
2 Completed Trial of Peg-Interferon Plus Epoetin-Alfa for Treatment of Chronic Hepatitis C Virus Infection
Condition: Hepatitis C
Interventions: Drug: Peginterferon-alpha-2b (PEG-Intron);   Drug: Ribavirin;   Drug: Epoetin-alpha (Procrit)
3 Withdrawn Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)
Conditions: HIV Infections;   Hepatitis B;   Hepatitis C
Interventions: Drug: Adefovir dipivoxil;   Drug: Peginterferon-alfa-2A;   Drug: Ribavirin;   Procedure: Liver Biopsy
4 Completed Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9
Conditions: Chronic Hepatitis C;   Asian Americans;   Novel Genotypes;   Treatment
Intervention: Drug: Pegylated interferon and ribavirin
5 Unknown  Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Neoplasms
Intervention: Drug: pegylated interferon alpha 2a and plus ribavirin
6 Unknown  Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Hepatocellular Carcinoma
Intervention: Drug: peginterferon alpha-2a  and ribavirin

Indicates status has not been verified in more than two years